Form 4: HCA Healthcare Director Frist Reports Share Reorganization

Sentiment:

Insider Ownership Change


Thomas F. Frist Jr., a Director and 10% owner of HCA Healthcare, reported a significant share reorganization involving Frisco Holding II.

Summary

  • Thomas F. Frist Jr., a Director and 10% owner of HCA Healthcare, Inc. (HCA), filed a Form 4 disclosing changes in beneficial ownership.
  • On February 6, 2026, Frisco Holding II, an entity affiliated with Mr. Frist, disposed of 36,629,188 shares of HCA Common Stock.
  • Concurrently, Frisco Holding II acquired 36,557,141 newly issued shares of HCA Common Stock in an exchange.
  • This transaction, along with Frisco's conversion to a partnership for U.S. federal income tax purposes, constituted a reorganization under Section 368(a) of the Internal Revenue Code.
  • The transactions were exempt from registration requirements of the Securities Act of 1933 and Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
  • Following the reorganization, Frisco Holding II beneficially owns 36,557,141 shares.
  • Mr. Frist disclaims beneficial ownership of Frisco's shares except for his pecuniary interest, which includes indirect interests in 846,050 shares through Frisco partnership units.
  • Mr. Frist also indirectly holds 32,282,889 shares through Hercules Holding II, with a pecuniary interest in 540,331 shares directly and 72,589 shares through trusts.
  • Mr. Frist directly owns 478,955 shares of HCA Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily a disclosure of a pre-planned internal share reorganization and tax conversion by a significant insider, with no direct positive or negative implications for company operations or financial performance.

Positives

  • The transaction was structured as a tax-exempt reorganization under Section 368(a) of the Internal Revenue Code.
  • The exchange was exempt from certain registration requirements and Section 16(b) liability under Rule 16b-3, indicating compliance with regulatory frameworks for such transactions.

Future Outlook

NA

Management Comments

  • The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
  • The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.

Industry Context

StockSavvy.ai notes that insider transaction disclosures like this Form 4 are routine for major shareholders and directors, providing transparency into ownership structures. While not directly indicative of operational performance, such reorganizations can reflect strategic tax planning or estate management by significant stakeholders in the healthcare industry.

Comparison to Industry Standards

  • This type of share reorganization, often involving holding companies and tax-exempt exchanges, is a common practice among high-net-worth individuals and family offices managing large stakes in publicly traded companies, similar to structures seen with major shareholders in companies like Johnson & Johnson or Pfizer.
  • The use of Rule 16b-3 for exemption from short-swing profit liability is standard for transactions between an issuer and its officers or directors, ensuring compliance with SEC regulations for internal corporate reorganizations.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Attorney-in-FactNAJ. William B. Morrow02/06/2026Appointment to handle SEC filings for Thomas F. Frist, Jr.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantThomas F. Frist, Jr. granted a Power of Attorney to J. William B. Morrow to prepare and submit SEC filings (Forms 3, 4, 5, Schedules 13D, 13G, and Forms 144) related to HCA Healthcare, Inc. securities.02/06/2026Enhances efficiency and ensures timely compliance with SEC reporting obligations for a significant insider.

Related Party Transactions

  • The share exchange involved Frisco Holding II, an entity held by a private investor group including affiliates of the Reporting Person (Thomas F. Frist Jr.).
  • Hercules Holding II, another entity holding HCA shares, is also held by a private investor group including affiliates of the Reporting Person.

Stakeholder Impact

  • Shareholders: Provides transparency regarding the ownership structure and tax planning activities of a major insider, but no direct operational impact.

Next Steps

  • Ongoing compliance with SEC reporting requirements for beneficial ownership changes.

Key Dates

DateDescription
02/06/2026Date of earliest transaction for share disposition and acquisition by Frisco Holding II, and execution date of Power of Attorney.
02/10/2026Signature date of the Form 4 filing by J. William B. Morrow, Attorney-in-Fact.

Recommendation

hold

This Form 4 filing details a pre-planned internal share reorganization and tax conversion by a significant insider, Thomas F. Frist Jr. It does not provide new information regarding HCA Healthcare's operational performance, financial health, or strategic direction. As such, it offers no basis for a change in investment thesis, warranting a 'hold' recommendation for existing investors.

Keywords

HCA Healthcare, Thomas F. Frist Jr., Form 4, Beneficial Ownership, Share Reorganization, Insider Trading, SEC Filing, Common Stock, Frisco Holding II, Hercules Holding II, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.